Latest Cancer News

Calquence Improves Survival in Relapsed Chronic Lymphocytic Leukemia (05-20-2019)
An interim analyses of the phase 3 “ASCEND” clinical trial evaluating single-agent Calquence (acalabrutinib) compared to Rituxan (rituximab) plus idelasib or bendamustine in recurrent chronic lymphocytic... Continue Reading

Zytig Treatment Prolongs Survival in Advanced Prostate Cancer (05-7-2019)
Zytig (Abiraterone acetate) plus prednisone and androgen deprivation therapy (ADT) significantly extends overall survival compared with placebo plus ADT in men with newly diagnosed high-risk metastatic... Continue Reading

FDA approves ivosidenib as first-line treatment for AML with IDH1 mutation (05-7-2019)
On May 2, 2019, the Food and Drug Administration approved ivosidenib (TIBSOVO, Agios Pharmaceuticals, Inc.) for newly-diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation, as detected... Continue Reading

More Cancer News

Locations

VIRGINIA BEACH OFFICE
1200 First Colonial Road
Suite 204
Virginia Beach, VA 23454
Phone (757)363-8212
Fax (757)363-2246
View Map

CHESAPEAKE OFFICE
Chesapeake Medical Center
110 Wimbledon Square
Suite E
Chesapeake, VA 23320
Phone (757)436-2995
Fax (757)436-2912
View Map

SUFFOLK OFFICE
Cancer Specialists of Tidewater
5839 Harbour View Blvd.,
Suite 100
Suffolk, VA 23435
Phone (757)397-4200
Fax (757)397-3872
View Map